When your digestion slows down due to a GLP-1 medication, these fermentable sugars have more time to sit in the gut and produce gas
It is estimated that the Asia-Pacific region will have the highest growth rate in the GLP-1 receptor agonist market with a CAGR of 14.7% in the period between 2026 and 2035 due to the soaring levels of diabetes and obesity, growing healthcare facilities, rising disposable incomes, and increasing awareness of the new advances in diabetes management
Whilst no documented interaction exists between inositol and Wegovy in UK prescribing information, this does not confirm safetyit simply means the combination has not been specifically studied
Access safety information - peptide safety and risks , common mistakes , peptide therapy clinics for supervised use
The primary mechanism of action involves stimulating insulin secretion from pancreatic beta cells in a glucose-dependent mannermeaning it only triggers insulin release when blood sugar levels are elevated